Mechanisms Underlying Myocardial Ischemia/Reperfusion Injury and Cardioprotective Strategies
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cells of the Cardiovascular System".
Deadline for manuscript submissions: 30 June 2024 | Viewed by 192
Special Issue Editors
Interests: regenerative medicine; cardiovascular diseases; aging; cancer biology; diabetes
Interests: muscle physiology; ion channels; protein therapeutics; regenerative medicine
Special Issue Information
Dear Colleagues,
In patients who suffer myocardial infarction due to an initial heart attack, post-myocardial infarction oxidative stress and inflammation can cause continuous injury to cardiomyocytes, leading to heart failure. Effective therapeutic approaches that enhance cardiomyocyte integrity and mitigate inflammation are urgently needed for the critical care of post-myocardial infarction patients. Current advances in stem cell biology, nano-drug delivery, and precision medicine have paved the way for innovative approaches to treat acute myocardial infarction and the transition to heart failure.
This Special Issue will examine the cellular and molecular bases that underlie the protection of myocardial integrity and control of inflammation that contribute to the regenerative process of the heart under stress, aging or infectious conditions. Engineering/delivery of stem cells, CRISPR-gene editing or AAV-gene delivery that can boost the regenerative process of the heart are of great interest for this Special Issue.
Prof. Dr. Jianjie Ma
Dr. Ki Ho Park
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- myocardial infarction
- heart failure
- stem cells
- nanoparticle
- aging
- diabetes
- transplantation
- CRISPR
- AAV
- tissue repair
- inflammation
- NETosis
- pyroptosis
- mitochondria
